Magnetar Financial’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
MB
BI
KCM
BOCH
AAA
RI
Magnetar Financial's CGEM Position: Q4 2025 in Review
Magnetar Financial sold out of Cullinan Oncology (CGEM) in Q4 2025, closing a stake of 26,263 shares — an estimated $156K sold.
Magnetar Financial first reported a position in CGEM in Q3 2025 and held it in 1 quarter. The position peaked at $156K in Q3 2025. 153 funds tracked by Wall St. Rank hold CGEM as of Q4 2025.
- Magnetar Financial reported no remaining Cullinan Oncology position as of Q4 2025 after selling out during the quarter.
- Magnetar Financial sold 26,263 Cullinan Oncology shares in Q4 2025, an estimated $156K.
- Magnetar Financial first reported a position in Cullinan Oncology in Q3 2025 and held it in 1 quarter.
- Magnetar Financial's Cullinan Oncology position peaked at $156K in Q3 2025.
- 153 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2025.
Based on Magnetar Financial's 13F filing for Q4 2025, filed 17 Feb 2026.